glucose, (beta-d)-isomer has been researched along with Bipolar Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyauchi, T | 1 |
| Huo, R; Li, H; Li, N; Shen, B; Sun, Y; Zhai, T; Zhang, J | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Bipolar Disorder
| Article | Year |
|---|---|
Valproate intoxication in a patient with bipolar I disorder due to SGLT2 inhibitor-induced weight reduction.
Topics: Aged; Antimanic Agents; Benzhydryl Compounds; Bipolar Disorder; Diabetes Mellitus, Type 2; Drug Interactions; Glucosides; Humans; Male; Sodium-Glucose Transporter 2 Inhibitors; Tremor; Valproic Acid; Weight Loss | 2020 |
Paeoniflorin selectively inhibits LPS-provoked B-cell function.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; B-Lymphocytes; Bipolar Disorder; Cell Differentiation; Cell Proliferation; Cells, Cultured; Female; Glucosides; Immunoglobulins; Lipopolysaccharides; Lymphocyte Activation; Mice, Inbred C57BL; Monoterpenes; Phytotherapy; Signal Transduction; Spleen; Toll-Like Receptor 4 | 2015 |